Journal of Pain Management & Medicine

Department of Pharmaceuticals Research, Pure Green Pharmaceuticals, West Bloomfield, 48323, USA

Biography

Deb Kimless oversees Pure Green Pharmaceutical's clinical medical testing,  patient and physician educational programs, and medical product development.   As a board-certified anesthesiologist and pain medicine specialist, she focuses on the pain-relieving aspects of cannabinoids and related substances for our FDA drug development program. Her recent election to the Bd. of Directors / Int’l Association for Cannabinoid Medicine has given her a world-wide educational platform for cannabis medicine. Deb graduated magna cum laude, Phi Beta Kappa from Muhlenberg College, earned her M.D. at Rutgers University and completed her anesthesiology residency at Temple University.

Publications

• Case Report   
  Low Dose Cannabidiol for the Treatment of Mild to Moderate Musculoskeletal Pain
  Author(s): Matthew K Caloura*, Debra Kimless, Susan Lewis and Stephen Goldner
  
  Sixteen healthy, cannabis and cannabidiol (CBD) naïve patients with mild to moderate musculoskeletal pain took a single dose of 5 mg CBD sublingual tablet. Patients were using other-the-counter (OTC) medications to treat various manifestations of musculoskeletal pain, including neck, back, muscle aches, and arthritis. The average self-reported pain scale score (NPRS), measured on a scale of 0-10, was 5.13 prior to taking the CBD tablet. After tablet administration, the patients self-reported their pain scale score over a 2-hour period. All patients reported pain reduction within 20 minutes after taking the tablet and continued over the 2-hour period where the average reported pain was reduced by 20-fold (NPRS 5.13 to 0.25) and was statistically significant (p<0.001). No patients reported any adverse effects and characterized the experience as positive. Th.. View more»
  

  DOI: 10.35248/2684-1320.21.7.156

  Abstract HTML PDF